Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 661-670 of 686 for cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Quality of Life Assessment of Patients with Biliary Obstruction Undergoing Endoscopic or Percutaneous Drainage

    Rochester, MN, Scottsdale/Phoenix, AZ, Jacksonville, FL

  2. Global Cardio Oncology Registry

    Rochester, MN

  3. Integration of Fluid Integration of Fluid and Imaging-Based Markers for Prostate Cancer

    Rochester, MN

  4. A Phase III, Randomised Study Of Adjuvant Dato-DXd In Combination With Rilvegostomig Or Rilvegostomig Monotherapy Versus Standard Of Care, Following Complete Tumour Resection, In Participants With Stage I Adenocarcinoma NSCLC Who Are CtDNA-positive Or Have High-risk Pathological Features

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Exploring Mechanisms of Action and Resistance of Therapeutic Agents in Patients with B-cell Malignancies

    Jacksonville, FL

  6. Specimen Collection from Participants Due for Colorectal Cancer Screening, Surveillance, or Treatment

    Rochester, MN

  7. A Study of Meaningful Symptom Change in Advanced Cancer Using Focus Groups

    Rochester, MN

  8. Quantitative Transmission Imaging Evaluation With MRI as Supplemental Screening to Mammography in Patients With High Lifetime Risk of Breast Cancer

    Rochester, MN

  9. Cell, Serum, and Buccal Bank for Patients with Chronic Myeloid Disorders and Acute Leukemia

    Rochester, MN

  10. A Study to Evaluate Immune and Hematopoietic Cell Assessment in Clonal B Cell Conditions

    Rochester, MN

.

Mayo Clinic Footer